Overview
The Wegovy pill is Novo Nordisk’s oral semaglutide tablet for chronic weight management — described by the company as the first and only oral GLP-1 for weight loss in adults. It gives patients access to semaglutide, the most extensively studied GLP-1 molecule, without injections.
The efficacy data comes from the OASIS 4 trial. Published results reported a mean change in body weight from baseline to week 64 of -13.6% with oral semaglutide 25 mg versus -2.2% with placebo. Topline reporting described 16.6% mean weight loss at 64 weeks with full adherence against 2.7% for placebo, and Novo’s own materials describe average weight loss of approximately 17% if all patients stayed on treatment against roughly 14% in the trial overall. Novo also reports that 76% of adults taking the Wegovy pill lost 5% or more of their weight compared with 31% on placebo.
Those figures put oral semaglutide close to injectable semaglutide territory and above what orforglipron achieved in its obesity program — a genuinely strong result for a tablet. Dosing runs through several strengths, with NovoCare’s self-pay pricing structured around 1.5 mg, 4 mg, 9 mg and 25 mg, and 25 mg serving as the maintenance dose studied in OASIS 4.
The trade-off is administration. Oral semaglutide is a peptide, and peptide absorption from the gut is poor and highly sensitive to conditions — which is why oral semaglutide carries specific administration requirements around food and liquid timing. Lilly explicitly markets Foundayo as the only GLP-1 pill without those restrictions, which tells you the Wegovy pill has them. Adherence to the dosing instructions directly affects how much drug you absorb, and therefore your results.
What Makes Wegovy Pill (Oral Semaglutide) Different
Semaglutide Without Injections
Semaglutide is the most extensively studied GLP-1 molecule, with a large body of cardiovascular and metabolic outcome data behind it. The Wegovy pill gives patients that molecule in tablet form, removing needles, refrigeration, injection technique and sharps disposal from the equation entirely.
Trial Results Close to Injectable Territory
OASIS 4 reported a mean 13.6% weight loss at 64 weeks on 25 mg versus 2.2% on placebo, with topline figures of 16.6% under full adherence. That is a stronger result than the oral GLP-1 competition and approaches what injectable semaglutide achieves.
76% of Participants Lost 5% or More
Novo reports that 76% of adults taking the Wegovy pill lost at least 5% of their body weight compared with 31% on placebo. The 5% threshold is clinically meaningful because it is where measurable improvements in blood pressure, lipids and glycemic markers typically begin.
Manufacturer Self-Pay Pricing From $149
NovoCare Pharmacy’s published self-pay schedule prices the tablet at $149 per month for 1.5 mg, $199 for 4 mg, and $299 for 9 mg and 25 mg. Novo has run the 4 mg dose at $149 through defined promotional windows. That is a fraction of what brand-name injectable semaglutide has historically cost.
✓ Pros
- •No injections required – oral tablet formulation
- •Strong trial results – 13.6% mean weight loss at 64 weeks in OASIS 4
- •76% achieved 5%+ weight loss – versus 31% on placebo
- •Semaglutide’s extensive evidence base – the most-studied GLP-1 molecule
- •No refrigeration required – simpler storage and travel than injectables
- •Self-pay from $149/month – through NovoCare Pharmacy
- •Widely available – NovoCare, GoodRx, Walgreens, Amazon Pharmacy, Sesame and others
- •FDA-approved – not a compounded preparation
✗ Cons
- •Food and water timing restrictions – absorption depends on following them precisely
- •Daily dosing – seven doses a week rather than one weekly injection
- •Price rises steeply with dose – $149 at 1.5 mg to $299 at the 25 mg maintenance dose
- •GLP-1 class boxed warning applies – thyroid C-cell tumors; review the prescribing information
- •Gastrointestinal side effects – common to the class and the leading cause of discontinuation
- •Adherence sensitivity – results under full adherence exceeded overall trial results notably
- •Less weight loss than injectable tirzepatide – which exceeds 20% in its trials
Our #1 Recommended Provider
The Wegovy pill is the strongest oral GLP-1 option on efficacy. If you want the lowest all-in monthly cost with clinical oversight included, Coreage RX remains our top overall recommendation.
Medications Offered
Brand-Name or Compounded?
Brand-name, FDA-approved. The Wegovy pill is an FDA-approved Novo Nordisk product. It is not compounded. Note that compounded oral semaglutide products marketed by some providers are a different thing entirely and are not equivalent to this approved tablet.
Wegovy pill 1.5 mg
$149/month self-pay via NovoCare PharmacyThe starting tablet dose. Titration begins here before escalating toward the maintenance dose.
Wegovy pill 4 mg
$199/month self-pay; $149/month during promotional windowsNovo has run the 4 mg dose at the $149 rate through defined promotional periods with published end dates. Confirm the current price when you order.
Wegovy pill 9 mg
$299/month self-pay via NovoCare PharmacyA higher tablet dose in the titration sequence.
Wegovy pill 25 mg
$299/month self-pay via NovoCare PharmacyThe maintenance dose studied in OASIS 4, which reported mean weight loss of 13.6% at 64 weeks versus 2.2% for placebo.
Through telehealth and pharmacy channels
Commonly $149/month at lower doses, $299/month at higher dosesGoodRx, Sesame and others have published pricing matching Novo’s self-pay schedule. Amazon One Medical has been reported at roughly $149 to $299 cash, or from $25/month with insurance coverage.
Budget around the maintenance dose, not the starting dose. The 25 mg dose studied in OASIS 4 is priced at $299 per month on Novo’s self-pay schedule — double the $149 entry price. A patient planning a year of treatment should model the higher figure.
Pricing, Membership & Medication Fees
| Cost Item | What You Pay |
|---|---|
| Wegovy pill 1.5 mg | $149/month self-pay |
| Wegovy pill 4 mg | $199/month self-pay; $149/month during promotional windows with published end dates |
| Wegovy pill 9 mg | $299/month self-pay |
| Wegovy pill 25 mg (maintenance) | $299/month self-pay |
| With insurance coverage | Depends on your formulary; Amazon has advertised GLP-1s from $25/month for covered patients |
| Available through | NovoCare Pharmacy, GoodRx, Walgreens Weight Management, Amazon Pharmacy, Sesame, Alloy, knownwell and others |
| Compounded version | Compounded oral semaglutide products are not equivalent to this FDA-approved tablet |
| Membership fees | None from Novo; telehealth channels may charge their own |
Compare channels carefully. NovoCare Pharmacy charges no membership fee. GoodRx adds $39 per month for care. Walgreens charges $49 per visit with no subscription. Sesame layers a program subscription on top. The medication price is broadly similar across channels because it tracks Novo’s self-pay schedule — what differs is the care layer.
How Wegovy Pill (Oral Semaglutide) Works
Confirm You Are a Candidate
Wegovy is approved for chronic weight management in adults with obesity, or overweight with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity. Your clinician makes this determination.
Review Contraindications
GLP-1 receptor agonists as a class carry an FDA boxed warning for thyroid C-cell tumors and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Review the prescribing information with your clinician.
Get a Prescription and Choose a Channel
Obtain a prescription from your own physician or a telehealth provider. Then choose a fulfillment channel — NovoCare Pharmacy charges no membership fee, while GoodRx, Walgreens, Amazon and Sesame each bundle their own care costs.
Learn the Administration Requirements Precisely
This is the step that determines your results. Oral semaglutide has specific requirements around food and liquid timing because peptide absorption from the gut is poor and condition-sensitive. Ask your pharmacist to walk you through it and follow the instructions exactly — trial results under full adherence were notably better than overall results.
Titrate Through the Dose Sequence
Dosing escalates through 1.5 mg, 4 mg, 9 mg and 25 mg. Escalation is gradual to manage gastrointestinal side effects. Note that your monthly cost doubles from $149 to $299 across that sequence.
Monitor and Adjust With Your Clinician
Report severe or persistent nausea, vomiting or abdominal pain rather than pushing through. Adequate protein intake and resistance training matter throughout, because a portion of weight lost on any GLP-1 is lean mass unless actively protected.
Program Details at a Glance
| Detail | Wegovy Pill (Oral Semaglutide) |
|---|---|
| Consultation process | Requires a prescription from a licensed clinician. Available through your own physician or telehealth providers including GoodRx, Walgreens, Amazon One Medical, Sesame, Alloy and knownwell. |
| Eligibility | FDA-approved for chronic weight management in adults with obesity, or overweight with at least one weight-related condition, used with a reduced-calorie diet and increased physical activity. |
| Provider involvement | Depends on the channel. NovoCare Pharmacy provides no clinical care; telehealth platforms include varying levels of support. |
| Lab requirements | Not universally required. Your clinician may order labs as part of standard evaluation and monitoring. |
| Pharmacy fulfillment | Dispensed as an FDA-approved Novo Nordisk product through NovoCare Pharmacy, retail pharmacies, and telehealth-partnered channels. |
| Shipping frequency | Monthly supply. As an oral tablet it does not require refrigeration or cold-chain shipping, unlike injectable semaglutide. |
| Support services | Varies entirely by the channel you purchase through. Compare the care layer, since medication pricing is broadly similar across channels. |
| Membership fee | None from Novo Nordisk. Telehealth channels may charge their own — for example GoodRx at $39/month, Walgreens at $49 per visit, or Sesame’s program subscription. |
| Medication fee | $149/month at 1.5 mg, $199/month at 4 mg (with promotional windows at $149), and $299/month at 9 mg and 25 mg on NovoCare’s self-pay schedule. |
| Cancellation policy | Not applicable to the medication. Any subscription terms belong to the telehealth channel you use. |
| Refund policy | Dispensed prescription medication is generally non-returnable. |
| Insurance | Coverage depends on your plan’s formulary. Prior authorization is common. Separate manufacturer savings pathways exist and are generally alternatives to the self-pay price rather than combinable with it. |
| HSA / FSA | Prescription medication costs are generally HSA/FSA eligible. Confirm with your plan administrator. |
| States served | Available across the United States, subject to your prescriber’s licensure and the channel’s coverage. |
Who Wegovy Pill (Oral Semaglutide) Is Best For
✓ Best For:
- • Patients who want semaglutide’s evidence base without injections
- • People with needle phobia or injection-related barriers to treatment
- • Patients who travel frequently and cannot manage refrigerated medication
- • Anyone who wants FDA-approved medication rather than compounded alternatives
- • Patients who can reliably follow specific daily administration instructions
- • People seeking oral GLP-1 therapy with the strongest available trial results
- • Patients whose insurance covers semaglutide for weight management
✗ Not Best For:
- • Patients who cannot reliably follow food and water timing requirements
- • People with a personal or family history of medullary thyroid carcinoma or MEN 2
- • Patients seeking maximum weight loss, where injectable tirzepatide leads
- • Anyone who struggles with daily medication adherence
- • Cost-sensitive patients who will reach the $299 maintenance dose tier
- • People who cannot tolerate GLP-1 class gastrointestinal effects
Limitations to Know Before You Sign Up
- ⚠️Oral semaglutide has specific administration requirements around food and liquid timing, and absorption depends on following them. The gap between full-adherence results (16.6%) and overall trial results (around 13.6%) illustrates how much this matters in practice.
- ⚠️The price doubles across the dose sequence, from $149 per month at 1.5 mg to $299 at the 25 mg maintenance dose. Budget around maintenance, not the entry price.
- ⚠️GLP-1 receptor agonists as a class carry an FDA boxed warning for thyroid C-cell tumors and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN 2.
- ⚠️Gastrointestinal side effects are common to the class and are the leading reason patients discontinue GLP-1 therapy.
- ⚠️Daily dosing offers seven weekly opportunities to miss a dose rather than one. For patients with fragile adherence, a weekly injection may actually be easier to sustain.
- ⚠️Injectable tirzepatide achieves greater weight loss in its trials. Patients whose priority is maximum efficacy should weigh that against the convenience of a tablet.
Alternatives to Wegovy Pill (Oral Semaglutide)
Foundayo (Orforglipron)
The other FDA-approved oral GLP-1, with no food or water timing restrictions but somewhat lower trial weight loss.
Wegovy / Ozempic
Injectable semaglutide, with the same molecule delivered weekly rather than daily.
NovoCare Pharmacy
Novo Nordisk’s manufacturer-direct channel for buying the Wegovy pill with no membership fee.
Coreage RX
Our top-rated provider at a flat $99/month with clinical oversight included.
Frequently Asked Questions
How much weight can you lose on the Wegovy pill?
OASIS 4 reported a mean change in body weight from baseline to week 64 of -13.6% with oral semaglutide 25 mg versus -2.2% with placebo. Topline reporting described 16.6% mean weight loss at 64 weeks with full adherence against 2.7% for placebo. Novo reports that 76% of adults taking the pill lost 5% or more of their weight compared with 31% on placebo. Individual results vary substantially.
How much does the Wegovy pill cost?
NovoCare Pharmacy’s published self-pay schedule prices it at $149 per month for 1.5 mg, $199 for 4 mg, and $299 for 9 mg and 25 mg. Novo has run the 4 mg dose at $149 through defined promotional windows. Prices at other channels broadly track this schedule, with the care layer differing.
Does the Wegovy pill have food and water restrictions?
Oral semaglutide has specific administration requirements around food and liquid timing, because peptide absorption from the gut is poor and condition-sensitive. Eli Lilly explicitly markets Foundayo as the only GLP-1 pill without such restrictions. Follow your prescribing information exactly — adherence directly affects how much drug you absorb.
Is the pill as good as the injection?
They are different formulations with separate trial programs and dosing, and are not interchangeable. OASIS 4’s results for the 25 mg tablet are strong and approach injectable semaglutide territory, but only your clinician can advise which formulation suits you. Do not assume equivalence from the shared brand name.
How does it compare to Foundayo?
The Wegovy pill reported higher trial weight loss — approximately 13.6% mean at 64 weeks versus about 11.1% for orforglipron in ATTAIN-1. Foundayo’s advantage is that it has no food or water timing restrictions. The choice comes down to whether you value efficacy or administrative simplicity more.
Does it need refrigeration?
No. As an oral tablet it does not require refrigeration or cold-chain shipping, which is a significant practical advantage over injectable semaglutide, particularly for travel.
Is compounded oral semaglutide the same thing?
No. Compounded oral semaglutide products marketed by some providers are not the FDA-approved Wegovy tablet and have not been through the same regulatory review. Do not treat them as equivalent.
Who should not take the Wegovy pill?
GLP-1 receptor agonists as a class are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Other contraindications and precautions apply — review the full prescribing information with your clinician.
The Bottom Line
The Wegovy pill earns 4.5 out of 5 stars for delivering semaglutide — the most extensively studied GLP-1 molecule — in tablet form with trial results that hold up. A mean 13.6% weight loss at 64 weeks in OASIS 4, rising to 16.6% under full adherence, with 76% of participants losing at least 5% of body weight, is the strongest oral GLP-1 efficacy data currently available.
For patients whose barrier to treatment is the injection itself, this is a genuine solution rather than a compromise. No needles, no refrigeration, no cold-chain shipping, no injection technique to learn, no sharps disposal. And at $149 per month self-pay for the starting dose through NovoCare Pharmacy with no membership fee, brand-name FDA-approved semaglutide has become accessible in a way it simply was not two years ago.
Two limitations matter. The administration requirements around food and liquid timing are real and consequential — the gap between full-adherence results and overall trial results exists precisely because those instructions are easy to get wrong. And the price doubles from $149 to $299 as you titrate to the 25 mg maintenance dose studied in OASIS 4, which changes the annual arithmetic considerably.
Our recommendation: The Wegovy pill is the strongest choice among oral GLP-1s if you can reliably follow the administration instructions. If those timing rules would be a problem for you, Foundayo has none, at somewhat lower reported efficacy. To buy it without paying a care membership, see NovoCare Pharmacy. And if you want the lowest all-in cost with clinical oversight bundled in, Coreage RX at $99/month remains our top overall pick.
Disclosure:
This review is based on publicly available information including Novo Nordisk’s own product, pharmacy and clinical pages, OASIS 4 trial reporting via peer-reviewed publication summaries and clinical trade press, and pricing published by NovoCare Pharmacy and third-party channels, current as of August 24, 2026. Presidential GLP-1 may receive compensation from some providers featured on this site, which helps us provide free, independent reviews; we do not have a compensation relationship with Novo Nordisk. Trial results describe average outcomes under study conditions and individual results vary substantially; reported figures differ depending on the analysis method used. Self-pay prices are subject to change and some dose-level offers carry published end dates. This page summarizes publicly reported information and is not a substitute for the FDA-approved prescribing information, which you should review with your clinician. We do not sell, dispense, or ship medication.
⚕️ Medical Disclaimer:
This review is for informational purposes only and is not medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications with serious risks and contraindications, including a boxed warning for thyroid C-cell tumors. Only a licensed clinician who knows your medical history can determine whether any weight-management medication is appropriate for you. Never start, stop, or change a prescription based on this page. If you experience severe abdominal pain, persistent vomiting, signs of an allergic reaction, or other concerning symptoms, seek medical care immediately. See our full medical disclaimer.
Or check out our top-rated provider